International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8087439
Case Report
Lemiere’s Syndrome Caused by Klebsiella Oxytoca; A Case Report
 ,
 ,
 ,
Published
May 6, 2023
Abstract
Lemiere’s syndrome is a rare but life-threatening condition which is most often preceded by an oropharyngeal infection. The most common organism involved is fusobacterium necrophorum, which is a part of normal flora of oropharynx. This case report describes a rare case of Klebsiella oxytoca associated Lemiere’s syndrome in a patient with poorly controlled Diabetes Mellitus. To our knowledge there has been only one single reported case of Lemiere’s syndrome caused by Klebsiella Oxytoca and this should be considered among the possible organism causing Lemiere’s syndrome. Though rare Lemiere’s syndrome carries a high mortality rate. Therefore clinicians should be familiar with signs and symptoms of the disease as well as the preemptive examinations, procedures and treatments.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1761 Views
115 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved